Finance

Lists
CLBT:NASDAQ
Cellebrite DI Ltd
$10.86
+4.07%
(+0.43) 1D
Aug 18, 1:18:28 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CLBT...
Open
$10.44
High
$10.91
Low
$10.32
Mkt. cap
2.72B
Avg. vol.
2.91M
Volume
2.77M
P/E ratio
46.83
52-wk high
$19.98
52-wk low
$9.58
EPS
$0.23
Beta
1.18
Shares outstanding
249.44M
No. of employees
1K
Open
$10.44
High
$10.91
Low
$10.32
Mkt. cap
2.72B
Avg. vol.
2.91M
Volume
2.77M
P/E ratio
46.83
52-wk high
$19.98
52-wk low
$9.58
EPS
$0.23
Beta
1.18
Shares outstanding
249.44M
No. of employees
1K
News stories
From web sources and news partners
Profile
Cellebrite DI Ltd. is a digital forensics company headquartered in Petah Tikva, Israel that provides tools for law enforcement agencies as well as enterprise companies and service providers to collect, review, analyze and manage digital data. Their flagship product series is the Cellebrite UFED. Cellebrite's largest shareholder is Sun Corporation, which is based in Nagoya, Japan. Cellebrite has fourteen offices around the world including business centers in Washington, D.C., Munich, and in Singapore. In 2021, the Cellebrite company was valued at approximately $2.4 billion. Wikipedia
About Cellebrite DI Ltd
CEO-
Employees1.28K
Founded1999
Headquarters-
SectorApplication software
Analyst ratings
Based on 8 analysts giving stock ratings to CLBT in the past 3 months
Strong buy
Buy
8
Hold
0
Sell
0
12-month forecast
Based on 8 Wall Street analysts offering 12 month price targets for CLBT in the last 3 months.
Highest
Current $10.86
$22.00 (+102.49%)
Average
$15.75 (+44.96%)
Lowest
$12.50 (+15.05%)
Analyst
Recommendation
Action
Price target
Projected
Date
Frank Takkinen
Lake Street
Buy
Reiterated
$15.00
+38.1%
08/14/2026
Unknown Analyst
Deutsche Bank
Buy
Maintained
$14.00
+28.9%
08/14/2026
Brian Essex
J.P. Morgan
Buy
Reiterated
$16.00
+47.3%
08/14/2026
Unknown Analyst
J.P. Morgan
Buy
Reiterated
$16.00
+47.3%
08/14/2026
Mike Cikos
Needham
Buy
Maintained
$12.50
+15%
08/14/2026
Shaul Eyal
TD Cowen
Buy
Maintained
$15.00
+38.1%
08/13/2026
Jonathan Ho
William Blair
Buy
Maintained
-
-
08/13/2026
Rudy Kessinger
D.A. Davidson
Buy
Maintained
$22.00
+102.5%
08/06/2026
Jeff Van Rhee
Craig-Hallum
Buy
Maintained
-
-
06/11/2026
Eric Martinuzzi
Lake Street
Buy
Reiterated
$21.00
+93.3%
05/14/2026
Last report
Aug 13, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
$0.11 / $0.11
-2.51%miss
Revenue / Est. (USD)
131.14M / 131.87M
-0.56%miss
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
126.03M
128.82M
128.30M
131.14M
Cost of goods sold
20.31M
19.69M
22.42M
25.21M
Cost of revenue
20.31M
19.69M
22.42M
25.21M
Research and development expenses
28.12M
29.86M
35.87M
35.96M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
58.60M
58.46M
60.89M
63.02M
Operating expense
86.72M
88.32M
96.76M
98.98M
Total operating expenses
107.04M
108.02M
119.18M
124.19M
Operating income
18.99M
20.80M
9.12M
6.95M
Other non operating income
-
-482.00K
-
-195.00K
EBT including unusual items
24.29M
26.27M
13.63M
11.19M
EBT excluding unusual items
24.29M
26.27M
13.63M
11.19M
Income tax expense
4.10M
5.01M
2.70M
4.82M
Effective tax rate
16.88%
19.07%
19.77%
43.05%
Other operating expenses
-
-
-
-
Net income
20.19M
21.26M
10.94M
6.37M
Net profit margin
16.02%
16.50%
8.53%
4.86%
Earnings per share
0.14
0.14
0.12
0.11
Interest and investment income
5.30M
5.21M
4.52M
5.54M
Interest expense
-
-
-
-
Net interest expenses
5.30M
5.21M
4.52M
5.54M
Depreciation and amortization charges
-
-
-
-
EBITDA
21.69M
24.75M
16.12M
15.86M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
AI content may include mistakes. Learn more
Google apps